Verapamil for Control of Ventricular Rate in Paroxysmal Supraventricular Tachycardia and Atrial Fibrillation or Flutter

1981 ◽  
Vol 94 (1) ◽  
pp. 1 ◽  
Author(s):  
HARVEY L. WAXMAN
Keyword(s):  
Atrial Fibrillation ◽  
Supraventricular Tachycardia ◽  
Ventricular Rate ◽  
Paroxysmal Supraventricular Tachycardia

Augmented Ventricular Rate Following Verapamil Treatment for Atrial Fibrillation with Wolff-Parkinson-White Syndrome

PEDIATRICS ◽  
1983 ◽  
Vol 72 (2) ◽  
pp. 245-246
Author(s):  
Thomas W. Rowland
Keyword(s):  
Atrial Fibrillation ◽  
Supraventricular Tachycardia ◽  
Refractory Period ◽  
Atrioventricular Node ◽  
Ventricular Rate ◽  
Paroxysmal Supraventricular Tachycardia ◽  
First Line ◽  
Ventricular Preexcitation ◽  
Line Drug ◽  
Wolff Parkinson White Syndrome

Verapamil has gained increasing acceptance as a first-line drug in the treatment of paroxysmal supraventricular tachycardia in both adults1 and children.2-4 Conversion to sinus rhythm in more than 90% of cases has been reported, an effect related to the drug's prolongation of refractory period and conduction through the atrioventricular node. The electrophysiologic effects of verapamil on accessory atrioventricular conduction pathways are more variable, and in some patients the drug will cause a decrease in refractory period.5-7 In individuals with reentrant paroxysmal supraventricular tachycardia this action is inconsequential, but in those with ventricular preexcitation accompanied by atrial fibrillation or flutter the effect may be catastrophic.

Observations on the occurrence of atrial fibrillation in paroxysmal supraventricular tachycardia

1986 ◽  
Vol 57 (8) ◽  
pp. 571-575 ◽  
Author(s):  
Steven F. Roark ◽  
Elizabeth A. McCarthy ◽  
Kerry L. Lee ◽  
Edward L.C. Pritchett
Keyword(s):  
Atrial Fibrillation ◽  
Supraventricular Tachycardia ◽  
Paroxysmal Supraventricular Tachycardia

scholarly journals Incidence of symptomatic atrial fibrillation in patients with paroxysmal supraventricular tachycardia

1995 ◽  
Vol 25 (5) ◽  
pp. 984-988 ◽  
Author(s):  
Mark E. Hamer ◽  
William E. Wilkinson ◽  
Walter K. Clair ◽  
Richard L. Page ◽  
Elizabeth A. McCarthy ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Supraventricular Tachycardia ◽  
Paroxysmal Supraventricular Tachycardia

ELECTROCARDIOGRAPHIC FINDINGS IN COVID-19

2020 ◽  
Vol 4 (1) ◽  
pp. 61-64
Author(s):  
M.R. Khidoyatova ◽  
◽  
G.Sh. Khamraeva
Keyword(s):  
Atrial Fibrillation ◽  
Supraventricular Tachycardia ◽  
Paroxysmal Supraventricular Tachycardia ◽  
Inflammatory Damage ◽  
Electrocardiographic Findings ◽  
Cardiac Disorders ◽  
Coronavirus Infection ◽  
Ecg Abnormalities

The spread of coronavirus infection poses a particular danger concerningcardiovascular lesions. In the situation of a pandemic caused by coronavirus infection, one of the available and informative methods for diagnosing cardiac disorders in patients with COVID-19 is electrocardiography. According to our observations, we described two cases of COVID-19, which showed different ECG manifestations, which caused a worsening of the course of the disease. In thefirst case, a paroxysm of atrial fibrillation was presented, in the second, paroxysmal supraventricular tachycardia. The mechanisms underlying these ECG abnormalities in severe COVID-19 may be associated with hypoxia and inflammatory damage caused by the virus

Sign in / Sign up

Export Citation Format

Share Document